Petros Pharmaceuticals Inc.
13F holders, Q4 2024 (December 31)9holders −2
0new positions
2sold out
$0.39avg. 13F price*
At the end of Q4 2024, 9 institutions reported holding Petros Pharmaceuticals Inc. in their 13F filings, down 2 from Q3 2024. 0 opened new positions and 2 sold out. The largest holders were Geode Capital Management, LLC ($14K), Vanguard Group Inc. ($13K) and BlackRock, Inc. ($6K).
- Company
- Petros Pharmaceuticals Inc.
- CUSIP
- 71678J209
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $13K |
All 13F filers, Q3 2024 → Q4 2024: 3 shares bought and 68,214 shares sold, net −68,211 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Geode Capital Management, LLC | 0.00% | Reduce -3.5% | 36,184 | $14K |
| Vanguard Group Inc. | 0.00% | No change | 31,811 | $13K |
| BlackRock, Inc. | 0.00% | No change | 16,128 | $6K |
| UBS Group AG | 0.00% | Reduce -70.6% | 12,992 | $5K |
| National Bank of Canada | 0.00% | Reduce -36.1% | 200 | $79 |
| Osaic Holdings, Inc. | 0.00% | No change | 200 | $78 |
| Group One Trading LLC | 0.00% | No change | 79 | $31 |
| Bank of America Corp. | 0.00% | Add +4.2% | 75 | $29 |
| Morgan Stanley | 0.00% | No change | 19 | $8 |
"% of holder's portfolio" is PETROS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Petros Pharmaceuticals Inc. the manager owns.